Vicore Announces Presentations at the 2024 American Thoracic Society International Conference
Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid in IPFAdditional presentations include preclinical and translational data...
United States Ahmed Mousa Hans Jeppsson Toby Maher Vicore Pharma Translational Research In Interstitial Abnormalities
Source: marketscreener.com